GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 372 filers reported holding GLOBUS MED INC in Q1 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $410,834,673 | -2.7% | 8,274,610 | +16.7% | 0.27% | +2.3% |
Q2 2023 | $422,189,648 | +11.4% | 7,090,854 | +6.0% | 0.26% | +5.2% |
Q1 2023 | $378,897,763 | -9.4% | 6,689,590 | +18.7% | 0.25% | -16.4% |
Q4 2022 | $418,433,838 | -0.4% | 5,633,954 | -60.0% | 0.30% | -4.8% |
Q3 2022 | $419,922,503 | +11.7% | 14,084,384 | +110.2% | 0.31% | +21.2% |
Q2 2022 | $376,094,000 | -22.7% | 6,699,208 | +1.6% | 0.26% | +10.2% |
Q1 2022 | $486,353,000 | +3.2% | 6,591,922 | +0.9% | 0.24% | +19.3% |
Q4 2021 | $471,490,000 | +6.7% | 6,530,337 | +13.2% | 0.20% | +2.1% |
Q3 2021 | $442,018,000 | -7.4% | 5,768,964 | -6.3% | 0.19% | -5.4% |
Q2 2021 | $477,382,000 | +20.5% | 6,157,383 | -4.1% | 0.20% | +12.7% |
Q1 2021 | $396,094,000 | -5.7% | 6,422,806 | -0.3% | 0.18% | -7.2% |
Q4 2020 | $420,132,000 | +33.5% | 6,441,759 | +1.4% | 0.20% | +18.9% |
Q3 2020 | $314,696,000 | -0.1% | 6,354,926 | -3.8% | 0.16% | -7.3% |
Q2 2020 | $315,069,000 | +9.4% | 6,603,845 | -2.5% | 0.18% | -10.6% |
Q1 2020 | $287,953,000 | -29.0% | 6,770,597 | -1.7% | 0.20% | -4.8% |
Q4 2019 | $405,421,000 | +10.3% | 6,885,555 | -4.2% | 0.21% | +4.5% |
Q3 2019 | $367,590,000 | +40.6% | 7,190,719 | +16.4% | 0.20% | +40.1% |
Q2 2019 | $261,397,000 | +56.7% | 6,179,600 | +83.1% | 0.14% | +54.3% |
Q1 2019 | $166,798,000 | +35.3% | 3,375,803 | +18.5% | 0.09% | +16.5% |
Q4 2018 | $123,294,000 | +58.0% | 2,848,754 | +107.2% | 0.08% | +88.1% |
Q3 2018 | $78,054,000 | +10.4% | 1,375,151 | -1.8% | 0.04% | +5.0% |
Q2 2018 | $70,692,000 | -48.7% | 1,400,950 | -49.3% | 0.04% | -50.6% |
Q1 2018 | $137,745,000 | -3.6% | 2,764,845 | -20.5% | 0.08% | -8.0% |
Q4 2017 | $142,901,000 | +51.1% | 3,476,905 | +9.3% | 0.09% | +44.3% |
Q3 2017 | $94,554,000 | +6.3% | 3,181,499 | +18.6% | 0.06% | +1.7% |
Q2 2017 | $88,952,000 | +303.0% | 2,683,312 | +260.0% | 0.06% | -61.3% |
Q1 2017 | $22,075,000 | +14.1% | 745,273 | -4.4% | 0.16% | +8.4% |
Q4 2016 | $19,340,000 | +10.1% | 779,516 | +0.2% | 0.14% | +10.9% |
Q3 2016 | $17,560,000 | -5.9% | 778,036 | -0.7% | 0.13% | -16.8% |
Q2 2016 | $18,664,000 | +58.1% | 783,235 | +57.6% | 0.16% | +61.5% |
Q1 2016 | $11,803,000 | -17.0% | 496,975 | -2.8% | 0.10% | -15.8% |
Q4 2015 | $14,229,000 | +91.1% | 511,467 | +41.9% | 0.11% | +72.7% |
Q3 2015 | $7,446,000 | +24.4% | 360,384 | +54.6% | 0.07% | +40.4% |
Q2 2015 | $5,984,000 | – | 233,117 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 373,254 | $26,949,000 | 17.58% |
Next Capital Management LLC | 111,098 | $8,021,000 | 5.42% |
Sterling Investment Advisors, Ltd. | 188,123 | $13,582,000 | 3.82% |
Integral Health Asset Management, LLC | 180,000 | $12,996,000 | 3.60% |
Pembroke Management, LTD | 602,447 | $43,497,000 | 3.19% |
Godshalk Welsh Capital Management, Inc. | 73,435 | $5,302,000 | 3.02% |
XXEC, Inc. | 51,925 | $3,420,000 | 2.92% |
Sivik Global Healthcare LLC | 75,000 | $5,415,000 | 2.32% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 654,100 | $47,226,000 | 2.11% |
Van Berkom & Associates Inc. | 929,856 | $67,136,000 | 1.98% |